US Safety Reporting Requirements during Pre-Market Clinical Trials

This course outlines the safety reporting requirements for significant and non-significant risk device clinical investigations in the US. The content adheres to the US FDA and US Institutional Review Boards. 

This course applies the requirements from CFR 812.150.